Article Details

Bitter Pill For Sun Pharma? Goldman Sachs Explains Why The Drugmaker May Face Pressure

Retrieved on: 2025-09-29 06:58:45

Tags for this article:

Click the tags to see associated articles and topics

Bitter Pill For Sun Pharma? Goldman Sachs Explains Why The Drugmaker May Face Pressure. View article details on hiswai:

Excerpt

Goldman Sachs has said the move won't have too much of an impact on Indian pharma companies, as a majority of them rely on generics as the main ...

Article found on: www.ndtvprofit.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo